These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28668813)

  • 1. The Herpes Zoster Vaccine in Rheumatic Diseases: Duration of Response.
    Shirley E; Chakravarty EF
    J Rheumatol; 2017 Jul; 44(7):968-969. PubMed ID: 28668813
    [No Abstract]   [Full Text] [Related]  

  • 2. In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years.
    Sacks HS
    Ann Intern Med; 2017 Jan; 166(2):JC5. PubMed ID: 28114461
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes zoster vaccine brings relief for the elderly.
    Morrow T
    Manag Care; 2006 Dec; 15(12):57-8. PubMed ID: 17260848
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlates of Protection for Herpes Zoster Vaccine: Evaluating Candidate Immunological Variables.
    Dunning AJ
    J Infect Dis; 2015 Nov; 212(9):1521. PubMed ID: 25985903
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
    Afonina NM; Mikheeva IV
    Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune senescence and vaccines to prevent herpes zoster in older persons.
    Levin MJ
    Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens.
    Miller G
    Clin Infect Dis; 2020 Jan; 70(2):191-192. PubMed ID: 30843045
    [No Abstract]   [Full Text] [Related]  

  • 8. Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine.
    Kim DH
    Cornea; 2019 Feb; 38(2):e5. PubMed ID: 30431474
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes Zoster Vaccine: Time for a Boost?
    Reddy KP
    J Gen Intern Med; 2017 Feb; 32(2):145-147. PubMed ID: 27730484
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoster vaccine in older adults.
    Fried R
    J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine.
    Young EJ
    Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378040
    [No Abstract]   [Full Text] [Related]  

  • 14. In Reply I-Risk of Disseminated Disease in Immunosuppressed Patients Receiving Live Zoster Vaccine.
    Bubb MR
    Mayo Clin Proc; 2016 Jul; 91(7):971. PubMed ID: 27378041
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpes zoster in people who are immunocompromised: what are the options for prevention?
    Warren-Gash C; Breuer J
    Lancet Infect Dis; 2019 Sep; 19(9):922-924. PubMed ID: 31399376
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes Zoster Vaccination Compliance: The Role of Specialist Rheumatology Nurses.
    Thakran RD; Baghel SS; Rawat R; Messi C
    J Rheumatol; 2017 Jun; 44(6):960. PubMed ID: 28572480
    [No Abstract]   [Full Text] [Related]  

  • 17. In Reply II-Risk of Disseminated Disease in Immunocompromised Patients Receiving Live Zoster Vaccine.
    Cheetham TC
    Mayo Clin Proc; 2016 Jul; 91(7):971-2. PubMed ID: 27378042
    [No Abstract]   [Full Text] [Related]  

  • 18. Q: Who should receive the shingles vaccine?
    Singh A; Englund K
    Cleve Clin J Med; 2009 Jan; 76(1):45-8. PubMed ID: 19122110
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
    Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
    Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoster vaccine: current status and future prospects.
    Oxman MN
    Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.